Literature DB >> 32242792

LPS stimulation during HCV infection induces MMP/TIMP1 imbalance in macrophages.

Chao Fan1,2, Xiaoxiao Zhang3, Peixin Zhang1, Jieru Zhao1, Huanjun Shen1, Ying Zhang1, Xingan Wu3, Zhansheng Jia1, Yili Wang2.   

Abstract

Introduction. During chronic hepatitis C virus (HCV) infections, HCV antigens establish cross-tolerance of endotoxins, but additional lipopolysaccharide (LPS) stimulation effects in this condition are poorly understood.Aim. This study aims to investigate the effects of the upregulated LPS on MMP and TIMP expression during chronic hepatitis C infection.Methodology. In the present study, we analysed the effect of HCV antigens and LPS stimulation on peripheral blood mononuclear cells (PBMCs) both in vivo and in vitro. Macrophages from HCV patients were isolated and their association with endotoxin tolerance was examined. MMP/TIMP1 expression and the related signalling pathways in macrophages were analysed. The macrophage and Huh7.5 cell co-culture model was used to analyse the effects of the cross-tolerance on collagen I deposition.Results. LPS levels were found to be significantly higher in HCV patients, particularly in those with HCV-induced liver fibrosis. In addition, although LPS serum level was occasionally upregulated in the patients, it did not induce intense immune response in PBMCs due to endotoxin cross-tolerance, and this was measured according to the changes in IL-6 and TNF-α levels. However, TIMP1 expression increased significantly during stimulation, exhibiting a tolerance/resistance phenotype, which was associated with TGF-β/Erk activation in macrophages. However, MMP levels did not increase due to endotoxin tolerance, which ultimately led to MMP/TIMP imbalance and influenced the deposition of collagen I.Conclusion. Increased LPS stimulation of macrophage during HCV antigen-induced endotoxin cross-tolerance contributes to MMP/TIMP1 imbalance and collagen I deposition.

Entities:  

Keywords:  Erk signal; HCV; TIMP1; endotoxin tolerance; liver fibrosis

Mesh:

Substances:

Year:  2020        PMID: 32242792     DOI: 10.1099/jmm.0.001185

Source DB:  PubMed          Journal:  J Med Microbiol        ISSN: 0022-2615            Impact factor:   2.472


  6 in total

1.  Sp1 induced gene TIMP1 is related to immune cell infiltration in glioblastoma.

Authors:  Lu Liu; Shuyao Yang; Kefeng Lin; Xiaoman Yu; Jiaqi Meng; Chao Ma; Zheng Wu; Yuchao Hao; Ning Chen; Qi Ge; Wenli Gao; Xiang Wang; Eric W-F Lam; Lin Zhang; Fangcheng Li; Bilian Jin; Di Jin
Journal:  Sci Rep       Date:  2022-07-01       Impact factor: 4.996

2.  Hypoxia- and Inflammation-Related Transcription Factor SP3 May Be Involved in Platelet Activation and Inflammation in Intracranial Hemorrhage.

Authors:  Ding Wan; Jin Feng; Peng Wang; Zhenxing Yang; Tao Sun
Journal:  Front Neurol       Date:  2022-06-02       Impact factor: 4.086

Review 3.  Heart Failure in Chronic Infectious and Inflammatory Conditions: Mechanistic Insights from Clinical Heterogeneity.

Authors:  Nour Beydoun; Matthew J Feinstein
Journal:  Curr Heart Fail Rep       Date:  2022-07-15

Review 4.  Cardiovascular Implications of Immune Disorders in Women.

Authors:  Caitlin A Moran; Lauren F Collins; Nour Beydoun; Puja K Mehta; Yetunde Fatade; Ijeoma Isiadinso; Tené T Lewis; Brittany Weber; Jill Goldstein; Igho Ofotokun; Arshed Quyyumi; May Y Choi; Kehmia Titanji; Cecile D Lahiri
Journal:  Circ Res       Date:  2022-02-17       Impact factor: 23.213

5.  The molecular feature of macrophages in tumor immune microenvironment of glioma patients.

Authors:  Hao Zhang; Yue-Bei Luo; Wantao Wu; Liyang Zhang; Zeyu Wang; Ziyu Dai; Songshan Feng; Hui Cao; Quan Cheng; Zhixiong Liu
Journal:  Comput Struct Biotechnol J       Date:  2021-08-14       Impact factor: 7.271

6.  Transient elastography score is elevated during rheumatoid factor-positive chronic hepatitis C virus infection and rheumatoid factor decline is highly variable over the course of direct-acting antiviral therapy.

Authors:  Ann W N Auma; Corinne Kowal; Carey L Shive; Alyssa Lange; Sofi Damjanovska; Elizabeth Zebrowski; Elane Reyes; Leonard Calabrese; Lenche Kostadinova; Yngve Falck-Ytter; Maya Mattar; Donald D Anthony
Journal:  PLoS One       Date:  2022-04-28       Impact factor: 3.752

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.